UnknownNCT05605145

PCP in Immunocompromised Population in Southern China

Studying Pneumocystosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
First Affiliated Hospital of Guangxi Medical University
Principal Investigator
Cunwei Cao, MD, MD
First Affiliated Hospital of Guangxi Medical University
Intervention
PCR was used to detect pneumocystis in respiratory specimens(diagnostic_test)
Enrollment
300 target
Eligibility
All sexes
Timeline
2021 – 2023

Study locations (1)

Collaborators

People's Hospital of Guangxi Zhuang Autonomous Region · The Fourth People's Hospital of Nanning · Chest Hospital of Guangxi Zhuang Autonomous Region · People's Hospital of Baise · LiuZhou People's Hospital · The second Nanning People's Hospital · The People's Hospital of Wuzhou · Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region · Second Affiliated Hospital of Guangzhou Medical University · 923rd Hospital of the People's Liberation Army

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05605145 on ClinicalTrials.gov

Other trials for Pneumocystosis

Additional recruiting or active studies for the same condition.

See all trials for Pneumocystosis →

← Back to all trials